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Objective To verify the feasibility of initial parameters of ultrasonography or electromyography for the prediction 
of eff  ect after steroid injection therapy in a carpal tunnel syndrome (CTS) patient.  
Method We recruited individuals with clinical and electrodiagnostic evidence of CTS. Results from the Boston 
self-assessment questionnaire, median motor and sensory nerve conduction studies, and median nerve 
ultrasonography were evaluated at baseline, 1 month, and 6 months after injection. Evaluation of median nerve 
ultrasonography parameters included measurements taken at the maximal swelling point (MS), 2 cm proximal 
from MS (2MS), and 12 cm proximal from MS (12MS), and its ratio (MS/12MS, 2MS/12MS) was calculated. Th  e 
correlation between improvement of the symptom score after treatment and baseline parameters was estimated.
Results Fourteen individuals (14 women, mean age 53.8 years) with 22 aff  ected wrists were enrolled. After steroid 
injection therapy, clinical and electromyographic parameters showed signifi  cant improvements at 1 month or 6 
months after injection, and ultrasonographic parameters showed signifi  cant changes in maximal area and area 
ratio (MS/12MS) of the median nerve. Symptom score improvement showed a positive correlation in the initial 
2MS and ratio of 2MS/12MS after 6 months (p<0.05).
Conclusion Most of the improvements occurred during the fi  rst month after injection and lasted up to 6 months. 
Th   e initial median nerve swelling and its ratio may be a useful predictor of response after steroid injection.
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INTRODUCTION
  Carpal tunnel syndrome (CTS), which is the most 
common disorder of peripheral neuropathy, is diagnosed 
based on medical history, physical examination, and 
electrodiagnostic (EDX) examination.
1,2 EDX examination 
is extremely useful for evaluation of the location of 
lesions and the severity of entrapment peripheral 
neuropathy.
3 
  Recently, many studies involving ultrasonography have 
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been conducted because the method is non-invasive, 
provides a real-time anatomical image of lesions, and it 
has been reported to help in the diagnosis of CTS.
4
  There are various CTS treatment options including 
nonsteroidal anti-inflammatory drugs, wrist splinting, 
steroid injection, and surgery. Among these methods, 
steroid injection is frequently used as an easy, simple, 
safe, and eff  ective treatment.
5
  However, the long-term eff  ects of steroid injections for 
CTS are debatable, and EDX parameters have shown 
limited improvement, when compared to clinical 
improvements.
6-8
  There have also been several studies conducted to 
investigate ultrasonographic changes following CTS 
surgery. However, few studies have been conducted 
to investigate ultrasonographic changes after steroid 
injection. Indeed, no studies have been conducted for 
follow-up of EDX examination with ultrasonography. 
  Therefore, in this study, we evaluated the long-
term effects of steroid injection in CTS patients by 
using changes in clinical, EDX, and ultrasonographic 
parameters. In addition, we examined the feasibility of 
using initial parameters to predict the effects of steroid 
injection therapy in CTS patients.
MATERIALS AND METHODS
Subjects
  CTS patients were enrolled based on their EDX criteria 
and clinical symptoms such as tingling sensation or 
pain in the first to third fingers, burning sensation, 
paresthesia, weakness of hand grip power, and muscle 
atrophy. 
  Patients with underlying metabolic disorders such as 
diabetes mellitus, genetic disorders, upper limb surgery, 
peripheral polyneuropathy, and traumatic nerve injury 
were excluded from this study. 
 
Methods
  Clinical assessment was conducted using the Boston 
self-assessment questionnaire (BQ), which is the most 
commonly used outcome measure of assessment for 
improvements in clinical symptoms and functional 
recovery of patients with CTS.
  EDX examination was conducted using Nicolet Viking 
IV
® (Nicolet Biomedical, Madison, WI, USA). Skin 
temperature of the hand was maintained above 32
oC, 
while a median motor nerve conduction study was 
employed to record the initial latency and baseline to 
peak amplitude from the abductor pollicis brevis muscle 
center (active site) while stimulation was performed at 
the wrist, 7 cm from the recording site. A median sensory 
nerve conduction study was employed to record the 
initial latency and baseline to peak amplitude from the 
3
rd fi  nger (active site), with retrograde stimulation being 
conducted at the wrist (14 cm proximal area from the 
recording site) and the palm (7 cm proximal area from the 
recording site). Th   e EDX criteria of CTS was determined 
based on a median motor latency >4.2 ms, median 
sensory onset latency >3.8 ms, or a ratio of proximal and 
distal onset latency > 2.0.
9   
  Ultrasonography studies were performed using a HDI 
3500 (ATL
®, Bothell, WA, USA) with a 12 MHz line array 
transducer. A physician, blinded to the EDX fi  ndings and 
clinical parameters, evaluated ultrasonography results. 
A perpendicular angle of the probe was maintained 
during analysis to prevent anisotropy and median nerve 
deformation, and additional weight was not permitted 
when pressure was applied on the skin surface with the 
probe. During analysis, patients were maintained in the 
supine position, with the forearm supinated and the wrist 
placed in a neutral position to prevent the appearance 
of the median nerve from changing according to wrist 
position. Cross-sectional area (CSA) was measured 
at 3 locations. The 3 locations of the median nerve 
ultrasonographic parameters included the maximal 
swelling point (MS) of the median nerve, 2 cm proximal 
from MS (2MS), and 12 cm proximal from MS (12MS). 
Following measurement, the CSA was calculated.
  The CSA of the median nerve was measured by 
continuous tracing of the nerve circumference, excluding 
the hyperechoic epineuria rim. The average value was 
reported based on 3 measurements. Using the CSAs of 
MS, 2MS, and 12MS, the CSA ratio of the median nerve 
was then calculated (MS/12MS, 2MS/12MS) (Fig. 1).
9 
  Each assessment was conducted at baseline, 1 month, 
and 6 months after injection.
  Conversely, to predict the eff  ect after a steroid injection, 
the correlation between improvement of the symptom 
score after 1 and 6 months of treatment, and baseline 
EDX and ultrasonographic parameters was estimated. Jin Seok Jeong, et al.
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Injection technique
  Th   e injection technique was conducted using the ulnar 
side approach proposed by Smith et al.
10 Briefl  y, with the 
wrist placed in a slight dorsiflexion, the injection was 
conducted under sterile conditions using a 26-gauge 
needle. Using real-time ultrasonography, 20 mg 
triamcinolone was injected into the ulnar side.  
  Specifically, 10 mg of triamcinolone was injected over 
the median nerve and under the flexor retinaculum, 
while the remainder was injected under the median 
nerve (Fig. 2). If the patient complained of paresthesia at 
the injection site, the needle was immediately withdrawn 
and repositioned.   
 
Statistical analysis
  Statistical analysis was conducted using SPSS 12.0. All 
parameters were calculated based on the mean and 
standard deviation, and were verifi  ed by the Kolmogorov-
Smirnov test. Repeated measures ANOVA was used 
to compare before and after injection parameters. 
The Spearman rank test was employed to identify the 
correlation of the degree of clinical improvement and 
initial parameters in the injection. p-values less than 0.05 
was considered to indicate statistical signifi  cance.
 
RESULTS
  Fourteen individuals (all women, mean age 53.8 years) 
with 22 aff  ected wrists were enrolled in this study (Table 1).
  Most parameters showed significant improvement 
at 1 month or 6 months after injection when they 
were compared with baseline parameters (Table 2). 
Fig. 1. (A) Placement of ultrasono-
graphic probe at the forearm. 
Ultrasonographic transverse scan 
was done at 3 different levels. We 
measured the cross sectional area 
of median nerve at the most swollen 
site level A, 2 cm proximal to this 
level B, 12 cm proximal to this level C. 
We calculated ratio of A/C, B/C. (B) 
Median nerve transverse sonogram 
image at A, B, C level.
Fig. 2. Transverse sonogram of the carpal tunnel in a patient with idiopathic carpal tunnel syndrome. (A) A 26-gauge needle 
(arrow) is shown passing from the ulnar aspect of the carpal tunnel to a position adjacent and deep to the median nerve. (B) A 
26-gauge needle (arrow) is shown passing from the ulnar aspect of the carpal tunnel to a position adjacent to the median nerve 
just below fl  exor retinaculum. MN: Median nerve .Usefulness of Ultra Sonography in CTS Injection Therapy
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Additionally, when compared with baseline parameters 
(mean 25.6), clinical parameters showed significant 
improvement at 1 month (mean 15.8) and 6 months 
(mean 14.7) after steroid injection.   
  Motor nerve latency and amplitude showed reduced 
and increased patterns with time, but latency differed 
signifi  cantly at 6 months after steroid injection (p<0.05). 
Sensory nerve latency and amplitude also showed 
shortened and increased patterns, but the latency 
differed significantly at 1 month and the amplitude 
differed significantly at 6 months after steroid injection 
(p<0.05).
  When compared with baseline parameters (mean 15.7 
mm
2), median nerve maximal swelling CSA showed 
significant improvement at 1 month (mean 12.8 mm
2) 
and 6 months (mean 12.3 mm
2) after steroid injection.   
  Th   e CSA ratio of the maximum swelling point (MS/12MS) 
also differed significantly following steroid injection 
(p<0.05). The CSA of 2MS and its ratio (2MS/12MS) 
showed a decreasing pattern following injection, but 
these fi  ndings did not diff  er signifi  cantly.
  When the results obtained at 1 and 6 months were 
compared, motor latency and sensory amplitude showed 
significant improvements, but the other parameters did 
not diff  er signifi  cantly. 
  To verify the feasibility of the initial parameters for the 
prediction of eff  ect after steroid injection therapy in CTS 
patients, we examined the Spearman rank test to identify 
the correlation of the degree of clinical improvement 
with the initial parameters (Table 3).
  EDX examination did not include prediction para-
meters, but the improvement in clinical score was 
positively related to the initial 2MS (mean 10.6 mm
2, r= 
0.510, p=0.022) and 2MS/12MS ratio (mean 1.8, r=0.529, 
p=0.017).
DISCUSSION
  Steroid injection is known to be a safe and effective 
treatment in CTS patients, and relieves local ischemia, 
inflammation, synovial swelling around the median 
nerve, and vascular congestion in carpal tunnel.
11,12
  Clinical and EDX parameters have been used to 
evaluate the eff  ectiveness of injection therapy. However, 
although EDX and clinical parameters showed signifi  cant 
improvement following steroid injection, there is no 
known correlation between EDX values and clinical 
scales.
13 In addition, the EDX test cannot be used to 
investigate anatomical variance because it is invasive, 
costly, and time consuming. Th   erefore, it is unreasonable 
to use EDX for long term follow-up of the effects of 
steroids. 
  Conversely, high-resolution ultrasonography enables 
Table 1. General Characteristics of Subjects
Characteristic Data
Sex M : F 0 : 14
Age (year) 53.8±11.1
Symptom duration (months) 6.2±6.7
Two hands aff  ected 8
Only right hand aff  ected 3
Only left hand aff  ected 3
Initial Pauda* scale  3.9±0.3
Initial HiOb scale     3±0.7
Values are mean±standard deviation
HiOb: Historical-Objective scale
*Electrophysiological Padua proposal scale
Table 2. Clinical, Electromyographic, and Ultra-
sonographic Data at Baseline, 1 and 6 Months after 
Injection (n=22)
Baseline 1 month 6 months
Symptom score  25.6±7.4 15.8±6.0* 14.7±4.4*
Functional score  13.2±4.6 10.2±3.2* 10.4±3.5*
Motor latency (ms) 5.3±1.2   5.1±1.1   4.6±0.6*
Motor amplitude (mV) 6.5±2.3   7.5±3.0*   7.7±2.4*
Sensory latency (ms) 4.5±1.3   4.2±1.2*   4.2±0.6
Sensory amplitude (uV) 16.9±10.2 18.3±8.5 22.5±13.1*
CSA at the wrist (mm
2)  15.7±3.7 12.8±4.0* 12.3±3.9*
CSA at 2 cm proximal
 of maximal CSA area
 (mm
2)
 10.6±2.6   9.8±2.8   9.9±3.1
Median nerve area ratio
 (maximal)
†
2.7±0.9   2.2±0.8*   2.1±0.7*
Median nerve area ratio
 (2 cm proximal)
‡
1.8±0.5   1.8±0.6   1.7±0.6
Values are mean±standard deviation
CSA: Cross sectional area
*The results of comparison between baseline, 1 month, 
and 6 months using repeated measure ANOVA are 
statistically signifi  cant at p<0.05, 
†Ratio of most swelling 
site to 12 cm proximal, 
‡Ratio of 2 cm proximal site to 12 
cm proximalJin Seok Jeong, et al.
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evaluation of the peripheral nerve anatomy without 
irradiation; blood flow can be viewed through Doppler 
imaging and it is non-invasive, less expensive, and less 
time consuming than EDX.        
  Mondelli et al.
14 reported post-operative changes in CTS 
patients. They found that ultrasonography was useful 
for the diagnosis of CTS, providing anatomical images 
of the median nerve, carpal tunnel, and neighboring 
structures, as well as for demonstrating improvement 
following surgical release. Moreover, they found direct 
correlations between CSA of the median nerve inlet 
and the clinical scale. In other words, the presurgical 
median nerve size of carpal tunnel inlet was smaller, the 
symptom scale easily decreased to the threshold level, so 
better outcomes are predicted. However, in this study, no 
correlation was observed between the BQ score and the 
CSA of the median nerve.
  Conversely, Naranjo et al.
15 conducted similar studies 
of postsurgery CTS patients. No correlation was found 
between the maximum CSA of the presurgical median 
nerve size and clinical scale improvement. Thus, the 
median nerve CSA measured by ultrasonography was 
useful for prediction of effect in CTS patients. Although 
these studies were conducted with postsurgical CTS 
patients, our study showed similar results.
  Cho et al.
9 reported that maximal CSA and its ratio can 
be used to reduce false positive findings due to median 
nerve CSA variations and interobserver diff  erences.   
  In this study, we identifi  ed the eff  ects of CTS injection 
therapy with EDX and ultrasonography and found that 
they were similar to the results of a previous study. 
Specifi  cally, the median nerve CSA and its ratio measured 
by ultrasonography showed significant improvement 
after steroid injection. Most improvements occurred 
during the fi  rst month of post-injection and lasted for 6 
months after CTS steroid injection therapy. 
  Baseline 2MS and its ratio measured by ultrasonography 
may be a useful predictor for the effects of steroid 
injection, because these parameters were found to be 
correlated with improvement of the clinical score.
  Entrapment peripheral neuropathy showed increasing 
nerve CSA at the entrapment site, with maximal 
nerve swelling typically being observed at the flexor 
retinaculum in CTS.
  However, the carpal tunnel is a very narrow space and 
the fl  exor retinaculum is a very rigid structure; therefore, 
nerve swelling is limited to a transverse increase, which 
results in longitudinal increases. Accordingly, 2MS and 
its ratio were useful for evaluating the effects of steroid 
treatment. 
  Ultrasonography in CTS is variable and controversial, 
and some studies have evaluated the median nerve CSA 
at the carpal tunnel inlet, outlet, and mid- portion.
14,16,17,19 
The present study only used the maximal CSA.
15 
After surgery, the CSA-inlet of the median nerve was 
decreased; however, some studies have shown that the 
CSA-outlet of the median nerve was increased.
14,16,17,19
  Accordingly, further research is needed to elucidate the 
mechanism by which median nerve swelling occurs, as 
well as the mechanism of improvement after treatment. 
It is also important to note that the present study was 
limited, in that only 22 aff  ected wrists were evaluated.
  To more clearly investigate the usefulness of ultra-
sonography to predict the response to injection therapy 
in CTS, additional studies are needed.   
  Finally, most of the CTS patients included in this study 
had mild symptoms; therefore, additional studies are 
needed to investigate the eff  ects according to the severity 
of disease.   
CONCLUSION
  Most improvements in carpal tunnel symptoms occurred 
during the fi  rst month of post-injection, and eff  ects lasted 
Table 3. Spearman Correlation Coeffi   cients of Symptom 
Improving and Baseline Parameters (n=22)
Correlation 
coeffi   cient
p-value
Motor latency (ms)   0.351 0.129
Motor amplitude (mV) –0.414 0.070
Sensory latency (ms) –0.035 0.884
Sensory amplitude (uV)   0.000 1.000
CSA at the wrist, maximal
 (mm
2)
  0.386 0.092
CSA at 2 cm proximal of
 maximal CSA area 
  0.510  0.022*
Median nerve area ratio
 (maximal)
†
  0.303 0.194
Median nerve area ratio
 (2 cm proximal)
‡
  0.529   0.017*
CSA: Cross sectional area
*p<0.05, 
†Ratio of most swelling site to 12 cm proximal, 
‡Ratio of 2 cm proximal site to 12 cm proximalUsefulness of Ultra Sonography in CTS Injection Therapy
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for up to 6 months during CTS steroid injection therapy. 
Th   e results of this study were confi  rmed by clinical, EDX, 
and ultrasonographic tests, and ultrasonography was 
found to have potential for use as a predictor to select 
patients after steroid injection, as well as a method for 
evaluation of steroid injection.
ACKNOWLEDGEMENTS
  This study was supported by a grant from the Korea 
Healthcare Technology R&D Project; Ministry for Health, 
Welfare & Family Aff  airs, Republic of Korea.
REFERENCES
1.  Gelberman RH, Rydevik BL, Pess GM, Szabo RM, 
Lundborg G. Carpal tunnel syndrome. A scientific 
basis for clinical care. Orthop Clin North Am 1988; 19: 
115-124
2.  Lee D, van Holsbeeck MT, Janevski PK, Ganos DL, 
Ditmars DM, Darian VB. Diagnosis of carpal tunnel 
syndrome. Ultrasound versus electromyography. 
Radiol Clin North Am 1999; 37: 859-872
3.  Jablecki CK, Andary MT, Floeter MK, Miller RG, 
Quartly CA, Vennix MJ, Wilson JR. Practice para-
meter: Electrodiagnostic studies in carpal tunnel 
syndrome. Report of the American Association of 
Electrodiagnostic Medicine, American Academy of 
Neurology, and the American Academy of Physical 
Medicine and Rehabilitation. Neurology 2002; 58: 
1589-1592
4.  Wong SM, Griffi   th JF, Hui AC, Lo SK, Fu M, Wong KS. 
Carpal tunnel syndrome: diagnostic usefulness of 
sonography. Radiology 2004; 232: 93-99
5.  Racasan O, Dubert T. The safest location for steroid 
injection in the treatment of carpal tunnel syndrome. 
J Hand Surg Br 2005; 30: 412-414
6.  Lee JH, An JH, Lee SH, Hwang EY. Effectiveness of 
steroid injection in treating patients with moderate 
and severe degree of carpal tunnel syndrome mea-
sured by clinical and electrodiagnostic assessment. 
Clin J Pain 2009; 25: 111-115
7.  Milo R, Kalichman L, Volchek L, Reitblat T. Local 
corticosteroid treatment for carpal tunnel syndrome: 
a 6-month clinical and electrophysiological follow-up 
study. J Back Musculoskelet Rehabil 2009; 22: 59-64
8.  Ucan H, Yagci I, Yilmaz L, Yagmurlu F, Keskin D, 
Bodur H. Comparison of splinting, splinting plus 
local steroid injection and open carpal tunnel release 
outcomes in idiopathic carpal tunnel syndrome. 
Rheumatol Int 2006; 27: 45-51
9.  Cho JM, Yoon JS, Kim SJ, Park BK, Lee GH, Jeong JS. 
Feasibility of ultrasonographic area ratio of median 
nerve in the diagnosis of carpal tunnel syndrome in 
Korea. J Korean Acad Rehab Med 2009; 33: 627-631
10. Smith J, Wisniewski SJ, Finnoff JT, Payne JM. 
Sonographically guided carpal tunnel injections: the 
ulnar approach. J Ultrasound Med 2008; 27: 1485-1490
11. Armstrong T, Devor W, Borschel L, Contreras R. 
Intracarpal steroid injection is safe and effective for 
short-term management of carpal tunnel syndrome. 
Muscle Nerve 2004; 29: 82-88
12. Hui AC, Wong S, Leung CH, Tong P, Mok V, Poon D, Li-
Tsang CW, Wong LK, Boet R. A randomized controlled 
trial of surgery vs steroid injection for carpal tunnel 
syndrome. Neurology 2005; 64: 2074-2078
13. Hagebeuk EE, de Weerd AW. Clinical and elec-
trophysiological follow-up after local steroid in  jec  tion 
in the carpal tunnel syndrome. Clin Neurophysiol 
2004; 115: 1464-1468
14. Mondelli M, Filippou G, Aretini A, Frediani B, Reale 
F. Ultrasonography before and after surgery in carpal 
tunnel syndrome and relationship with clinical 
and electrophysiological findings. A new outcome 
predictor? Scand J Rheumatol 2008; 37: 219-224
15. Naranjo A, Ojeda S, Arana V, Baeta P, Fernandez-
Palacios J, Garcia-Duque O, Rodriguez-Lozano C, 
Carmona L. Usefulness of clinical findings, nerve 
conduction studies and ultrasonography to predict 
response to surgical release in idiopathic carpal 
tunnel syndrome. Clin Exp Rheumatol 2009; 27: 786-
793
16. Abicalaf CA, de Barros N, Sernik RA, Pimentel BF, 
Braga-Baiak A, Braga L, Houvet P, Brasseur JL, Roger 
B, Cerri GG. Ultrasound evaluation of patients with 
carpal tunnel syndrome before and after endoscopic 
release of the transverse carpal ligament. Clin Radiol 
2007; 62: 891-894
17. Colak A, Kutlay M, Pekkafali Z, Saracoglu M, De-
mi  rcan N, Simsek H, Akin ON, Kibici K. Use of 
sono  graphy in carpal tunnel syndrome surgery. A 
prospective study. Neurol Med Chir 2007; 47: 109-115Jin Seok Jeong, et al.
394 www.e-arm.org
18. Hammer HB, Hovden IA, Haavardsholm EA, Kvien 
TK. Ultrasonography shows increased cross-sectional 
area of the median nerve in patients with arthritis and 
carpal tunnel syndrome. Rheumatology 2006; 45: 584-
588
19. Lee CH, Kim TK, Yoon ES, Dhong ES. Postoperative 
morphologic analysis of carpal tunnel syndrome using 
high-resolution ultrasonography. Ann Plast Surg 2005; 
54: 143-146
   